Abstract
Background: Hypertrophic cardiomyopathy represents a co-morbidity in infants. It is characterized by thickening of one or both of the ventricular walls including the interventricular septum in addition to systolic and diastolic dysfunction.Gestational diabetes mellitus (GDM) with poorly controlled glycemia is associated with poor pregnancy outcomes. However, adequate markers for glycemic control in GDM have not been fully evaluated. Hypertrophic cardiomyopathy represents a co-morbidity in infants. It is characterized by thickening of one or both of the ventricular walls including the interventricular septum in addition to systolic and diastolic dysfunction. Summary: In summary, we demonstrated the clinical usefulness of GA and GA/HbA1c in monitoring GDM in late pregnancy and predicting infant complications of GDM. Our data suggested that the use of GA and GA/HbA1c in combination with conventional glycemic control indices might be useful for good glycemic control during pregnancy, although our results need validation in larger, better-designed studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
